Related references
Note: Only part of the references are listed.BTN3A2 serves as a prognostic marker and favors immune infiltration in triple-negative breast cancer
Peian Cai et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2020)
Butyrophilin 2A1 is essential for phosphoantigen reactivity by γδ T cells
Marc Rigau et al.
SCIENCE (2020)
Butyrophilin-2A1 Directly Binds Germline-Encoded Regions of the Vγ9Vδ2 TCR and Is Essential for Phosphoantigen Sensing
Mohindar M. Karunakaran et al.
IMMUNITY (2020)
ImmuCellAI: A Unique Method for Comprehensive T-Cell Subsets Abundance Prediction and its Application in Cancer Immunotherapy
Ya-Ru Miao et al.
ADVANCED SCIENCE (2020)
Head and Neck Cancer
Laura Q. M. Chow
NEW ENGLAND JOURNAL OF MEDICINE (2020)
A Structural Change in Butyrophilin upon Phosphoantigen Binding Underlies Phosphoantigen-Mediated Vγ9Vδ2 T Cell Activation
Yunyun Yang et al.
IMMUNITY (2019)
Determining cell type abundance and expression from bulk tissues with digital cytometry
Aaron M. Newman et al.
NATURE BIOTECHNOLOGY (2019)
Cooperation between Constitutive and Inducible Chemokines Enables T Cell Engraftment and Immune Attack in Solid Tumors
Denarda Dangaj et al.
CANCER CELL (2019)
Oral diseases: a global public health challenge
Marco A. Peres et al.
LANCET (2019)
α-GalCer and iNKT Cell-Based Cancer Immunotherapy: Realizing the Therapeutic Potentials
Yingting Zhang et al.
FRONTIERS IN IMMUNOLOGY (2019)
Immune Networks and Therapeutic Targeting of iNKT Cells in Cancer
Shin-Ichiro Fujii et al.
TRENDS IN IMMUNOLOGY (2019)
γδ T cells: pleiotropic immune effectors with therapeutic potential in cancer
Bruno Silva-Santos et al.
NATURE REVIEWS CANCER (2019)
BTN3A is a prognosis marker and a promising target for V gamma 9V delta 2 T cells based-immunotherapy in pancreatic ductal adenocarcinoma (PDAC)
Audrey Benyamine et al.
ONCOIMMUNOLOGY (2018)
Heteromeric interactions regulate butyrophilin (BTN) and BTN-like molecules governing gamma delta T cell biology
Pierre Vantourout et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
gamma delta T cell responses: How many ligands will it take till we know?
David Vermijlen et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2018)
Protective Role of γδ T Cells in Different Pathogen Infections and Its Potential Clinical Application
Yueshui Zhao et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2018)
Molecular Determinants of Target Cell Recognition by Human γδ T Cells
Andre E. Simoes et al.
FRONTIERS IN IMMUNOLOGY (2018)
New Insights Into the Regulation of γδ T Cells by BTN3A and Other BTN/BTNL in Tumor Immunity
Juan-Luis Blazquez et al.
FRONTIERS IN IMMUNOLOGY (2018)
Bystander CD8+ T cells are abundant and phenotypically distinct in human tumour infiltrates
Yannick Simoni et al.
NATURE (2018)
Treatment-naive HPV plus head and neck cancers display a T-cell-inflamed phenotype distinct from their HPV- counterparts that has implications for immunotherapy
Steven F. Gameiro et al.
ONCOIMMUNOLOGY (2018)
Exome Array Analysis Identifies Variants in SPOCD1 and BTN3A2 That Affect Risk for Gastric Cancer
Meng Zhu et al.
GASTROENTEROLOGY (2017)
The Transcription Factor Hobit Identifies Human Cytotoxic CD4+ T Cells
Anna E. Oja et al.
FRONTIERS IN IMMUNOLOGY (2017)
Dual Face of Vγ9Vδ2-T Cells in Tumor Immunology: Anti-versus Pro-Tumoral Activities
Zheng Xiang et al.
FRONTIERS IN IMMUNOLOGY (2017)
Tumor-infiltrating gamma delta T cells predict prognosis and adjuvant chemotherapeutic benefit in patients with gastric cancer
Jieti Wang et al.
ONCOIMMUNOLOGY (2017)
γδ T cells in homeostasis and host defence of epithelial barrier tissues
Morten M. Nielsen et al.
NATURE REVIEWS IMMUNOLOGY (2017)
NKG2D-and T-cell receptor-dependent lysis of malignant glioma cell lines by human T cells: Modulation by temozolomide and A disintegrin and metalloproteases 10 and 17 inhibitors
Guranda Chitadze et al.
ONCOIMMUNOLOGY (2016)
Tumor-Associated Neutrophils Recruit Macrophages and T-Regulatory Cells to Promote Progression of Hepatocellular Carcinoma and Resistance to Sorafenib
Shao-Lai Zhou et al.
GASTROENTEROLOGY (2016)
Regulatory and effector functions of gamma-delta (γδ) T cells and their therapeutic potential in adoptive cellular therapy for cancer
Sourav Paul et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial
Tanguy Y. Seiwert et al.
LANCET ONCOLOGY (2016)
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
R. L. Ferris et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
RhoB Mediates Phosphoantigen Recognition by Vγ9Vδ2 T Cell Receptor
Zsolt Sebestyen et al.
CELL REPORTS (2016)
The head and neck cancer immune landscape and its immunotherapeutic implications
Rajarsi Mandal et al.
JCI INSIGHT (2016)
Oral cavity and oropharyngeal squamous cell carcinomaan update
Angela C. Chi et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Activation of Human γδ T Cells by Cytosolic Interactions of BTN3A1 with Soluble Phosphoantigens and the Cytoskeletal Adaptor Periplakin
David A. Rhodes et al.
JOURNAL OF IMMUNOLOGY (2015)
The prognostic landscape of genes and infiltrating immune cells across human cancers
Andrew J. Gentles et al.
NATURE MEDICINE (2015)
Prognostic value of tumor-infiltrating FoxP3+ regulatory T cells in cancers: a systematic review and meta-analysis
Bin Shang et al.
SCIENTIFIC REPORTS (2015)
Low Counts of γδ T Cells in Peritumoral Liver Tissue are Related to More Frequent Recurrence in Patients with Hepatocellular Carcinoma after Curative Resection
Xiao-Yan Cai et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
γδT17 Cells Promote the Accumulation and Expansion of Myeloid-Derived Suppressor Cells in Human Colorectal Cancer
Pin Wu et al.
IMMUNITY (2014)
The Intracellular B30.2 Domain of Butyrophilin 3A1 Binds Phosphoantigens to Mediate Activation of Human Vγ9Vδ2 T Cells
Andrew Sandstrom et al.
IMMUNITY (2014)
Phosphoantigens and butyrophilin 3A1 induce similar intracellular activation signaling in human TCRVγ9+ γδ T lymphocytes
Emilie Decaup et al.
IMMUNOLOGY LETTERS (2014)
Phenotypic and Functional Plasticity of Gamma-Delta (γδ) T Cells in Inflammation and Tolerance
Sourav Paul et al.
INTERNATIONAL REVIEWS OF IMMUNOLOGY (2014)
Human gamma delta T regulatory cells in cancer: fact or fiction?
Daniela Wesch et al.
FRONTIERS IN IMMUNOLOGY (2014)
Stress-related and homeostatic cytokines regulate Vγ9Vδ2 T-cell surveillance of mevalonate metabolism
Georg Gruenbacher et al.
ONCOIMMUNOLOGY (2014)
Immune modulation by butyrophilins
Heather A. Arnett et al.
NATURE REVIEWS IMMUNOLOGY (2014)
Mechanisms underlying lineage commitment and plasticity of human γδ T cells
Nadia Caccamo et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2013)
Butyrophilin Btn2a2 Inhibits TCR Activation and Phosphatidylinositol 3-Kinase/Akt Pathway Signaling and Induces Foxp3 Expression in T Lymphocytes
Johannes U. Ammann et al.
JOURNAL OF IMMUNOLOGY (2013)
Butyrophilin 3A1 binds phosphorylated antigens and stimulates human γδ T cells
Stefano Vavassori et al.
NATURE IMMUNOLOGY (2013)
Innate and adaptive immune cells in the tumor microenvironment
Thomas F. Gajewski et al.
NATURE IMMUNOLOGY (2013)
An interleukin-17-mediated paracrine network promotes tumor resistance to anti-angiogenic therapy
Alicia S. Chung et al.
NATURE MEDICINE (2013)
Key implication of CD277/butyrophilin-3 (BTN3A) in cellular stress sensing by a major human γδ T-cell subset
Christelle Harly et al.
BLOOD (2012)
Mutant p53 Disrupts Mammary Tissue Architecture via the Mevalonate Pathway
William A. Freed-Pastor et al.
CELL (2012)
Tumor-Infiltrating γδ T Lymphocytes Predict Clinical Outcome in Human Breast Cancer
Chunling Ma et al.
JOURNAL OF IMMUNOLOGY (2012)
BTN3A2 Expression in Epithelial Ovarian Cancer Is Associated with Higher Tumor Infiltrating T Cells and a Better Prognosis
Cecile Le Page et al.
PLOS ONE (2012)
Measurement of mRNA abundance using RNA-seq data: RPKM measure is inconsistent among samples
Gunter P. Wagner et al.
THEORY IN BIOSCIENCES (2012)
Butyrophilins: an emerging family of immune regulators
Lucie Abeler-Doerner et al.
TRENDS IN IMMUNOLOGY (2012)
The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis
M. J. M. Gooden et al.
BRITISH JOURNAL OF CANCER (2011)
Rapamycin increases the yield and effector function of human γδ T cells stimulated in vitro
Haishan Li et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
γδ T-APCs: a novel tool for immunotherapy?
Bernhard Moser et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2011)
CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis
Bin-Zhi Qian et al.
NATURE (2011)
The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM
Stephen B. Edge et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Human γδ T lymphocytes induce robust NK cell-mediated antitumor cytotoxicity through CD137 engagement
Amudhan Maniar et al.
BLOOD (2010)
In vivo manipulation of Vγ9Vδ2 T cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients
S. Meraviglia et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
BTN1A1, the Mammary Gland Butyrophilin, and BTN2A2 Are Both Inhibitors of T Cell Activation
Isobel A. Smith et al.
JOURNAL OF IMMUNOLOGY (2010)
γδT cells initiate acute inflammation and injury in adenovirus-infected liver via cytokine-chemokine cross talk
Maureen N. Ajuebor et al.
JOURNAL OF VIROLOGY (2008)
Lysis of a broad range of epithelial tumour cells by human γδ T cells:: Involvement of NK62D ligands and T-cell receptor- versus NKG2D-dependent recognition
P. Wrobel et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2007)
Soluble MIC is elevated in the serum of patients with pancreatic carcinoma diminishing γδ T cell cytotoxicity
Angela Maerten et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Gamma-delta T-cells in patients with squamous cell carcinoma of the head and neck
Murat Bas et al.
ORAL ONCOLOGY (2006)
Vδ1 T lymphocytes from B-CLL patients recognize ULBP3 expressed on leukemic B cells and up-regulated by trans-retinoic acid
A Poggi et al.
CANCER RESEARCH (2004)
Human T cell receptor γδ cells recognize endogenous mevalonate metabolites in tumor cells
HJ Gober et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Share Paper
